This page is used for Login Customizer plugin. It will not be visible to your readers. Do not delete it.
- Tollys extends its executive management team with appointment of Bettina Werle as CSO
- Tollys receives over €1.5 million deep tech financing from Bpifrance
- Tollys closes Series A financing of €2.3 million
- Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma
- Corrigendum to “Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis” [J Hepatol 71 (2019) 763-772]